Biotech entity
They are less corroborated than the beat average, carrying 2 original sources each against 4.4 for the same window. The clearest coverage concentration is pharma: 2 of 3 stories, with the rest divided among 1 other category. Bavarian Nordic is the most frequent co-covered peer, appearing in 1 of the 3 tracked stories.
Last mentioned: Mar 21, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 67 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
They are less corroborated than the beat average, carrying 2 original sources each against 4.4 for the same window. The clearest coverage concentration is pharma: 2 of 3 stories, with the rest divided among 1 other category. Bavarian Nordic is the most frequent co-covered peer, appearing in 1 of the 3 tracked stories. Across a 131-day span, the pace is roughly 0.2 stories per week. Their average consequence score of 6.7 runs above the beat's 6.3 for that window. We currently track 3 Biotech stories that mention Missouri, published between March 13, 2026 and July 21, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 314 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Missouri. Shared-story counts are live from our verified record — not editorial picks.
Public Notification
Official announcement made to the public and healthcare providers regarding state status.
Initial Diagnosis
Missouri DHSS confirms two positive test results for mpox.
Contact Tracing Launch
Public health officials begin identifying close contacts of the two patients.
Missouri Pause Request
DOJ files a request in federal court to pause the Missouri-led lawsuit citing an ongoing FDA review.
Hawley Federal Bill
Senator Josh Hawley introduces a bill in the Senate to ban mifepristone nationwide.
Louisiana Pause Request
DOJ asks Louisiana to pause its separate lawsuit; request is rejected by AG Liz Murrill.
Missouri Lawsuit Filed
Missouri, Kansas, and Idaho file suit against the FDA to restrict mifepristone access.
Regulatory chaos after Dobbs is freezing innovation in miscarriage management drugs and devices, delaying emergency care and leaving a $2.3 billion women’s health market in limbo. Vague exceptions in 13 state bans create a minefield for pharma companies developing early pregnancy loss treatments.
Source: reporterherald.com · sun-sentinel.com
The Missouri Department of Health and Senior Services has confirmed the state's first two cases of mpox (monkeypox), marking the virus's official entry into the state. Health officials have launched immediate contact tracing efforts to contain potential community spread and are coordinating with federal partners for vaccine distribution.
The Department of Justice has requested a federal court to pause a multi-state lawsuit against the FDA regarding the abortion pill mifepristone. The move suggests a strategic effort to allow the FDA to conduct its own internal review of the drug's safety and distribution protocols.
Missouri is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
